Prestige Consumer Healthcare Inc. (PBH)
PBHNYSEBiotechnology: Pharmaceutical Preparations
$43.67
0.0000 (0.00%) today
Pre-market, Nov 9, 4:00 PM ET
- Market cap
- $2.07bn
- P/E
- 9.8
- EPS, last 4 quarters
- $4.48
- Dividend yield
- –
- Day range
- –
- 52-week range
- $42.62 to $71.07
- Average volume
- 388.3k
- Previous close
- $43.67
Analysts
1 coveringHold1 buy, 0 hold, 0 sell
Targets a year out average $70.00, +60.3% from here
Earnings
next estimate $1.14Next report
Dec 2025
-1.7%
Mar 2026
-11.5%
Jun 2026
+10.1%
Sep 2026
+6.6%
estimate reported, and the surprise
Financials
| Quarter | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| Revenue | $283.44m | $281.62m | $265.71m | $336.31m |
| Gross profit | $157.37m | $146.30m | $136.19m | $172.54m |
| Operating income | $82.49m | $75.49m | $52.52m | $80.71m |
| Net income | $46.70m | $53.93m | $29.18m | $25.30m |
Last four quarters: revenue $1.17bn, margin 13.3%, free cash flow $214.22m
News
8 latest- Prestige Consumer Healthcare Q2 Earnings Call HighlightsMarketBeat · 2 days ago
- Prestige Healthcare (PBH) Q2 2027 Earnings Call TranscriptThe Motley Fool · 5 days ago
- Compared to Estimates, Prestige Consumer Healthcare (PBH) Q2 Earnings: A Look at Key MetricsZacks · 5 days ago
- Prestige Consumer Healthcare Inc. Reports Q2 Revenue of $336.3 million and Updates Fiscal 2027 OutlookFintel · 5 days ago
- Prestige Consumer Healthcare (PBH) Beats Q2 Earnings and Revenue EstimatesZacks · 5 days ago
- biote Corp. (BTMD) Tops Q3 Earnings EstimatesZacks · 5 days ago
- GE HealthCare Technologies (GEHC) Q3 Earnings and Revenues Beat EstimatesZacks · Oct 28, 2026
- Is it Apt to Retain Prestige Consumer Stock in Your Portfolio Now?Zacks · Oct 15, 2026
The company
Prestige Consumer Healthcare Inc. (NYSE: PBH) is a leading consumer healthcare company growing trusted, category-defining brands. Headquartered in New York , the Company markets, sells, manufactures and distributes its products across the U.S ., Canada , Australia , and select other international markets. Its diverse portfolio of iconic brands includes Breathe Right, Monistat, Summer's Eve, BC, Goody's, Dramamine, Fleet, Hydralyte, Gaviscon, DenTek, TheraTears, Clear Eyes, Compound W, Dermal Therapy, Chloraseptic, Luden's, Little Remedies, Boudreaux's Butt Paste, Nix, and Debrox, among others. Learn more at www.prestigeconsumerhealthcare.com .
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Exchange
- NYSE
- Region
- North America
- Website
- prestigebrands.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.